-
McIlroy hoping for 'home' comforts at Scottish, British Opens
-
Britain's Fery to face Zverev in Wimbledon semi-finals
-
Noskova aims to emulate Kvitova after reaching first Wimbledon semi
-
Zverev sees off Fritz to make first Wimbledon semi-final
-
Britain's Fery becomes first wildcard to reach Wimbledon semis in 25 years
-
Barcelona sets new heat record at 40.7C: weather agencies
-
Korda chases third major as Kim revisits Evian-winning chip
-
'The Pitt,' 'Hacks' lead Emmy nominations
-
Kooij wins Tour de France 5th stage in chaotic sprint finish
-
France lose appeal against Olise booking at World Cup
-
Trump says Ukraine can make Patriot missiles
-
Putellas joins star cast at London City Lionesses
-
Teenager arrested after two girls wounded in Germany school attack
-
Oil back at $80, stocks slide as Trump says Iran ceasefire over
-
Farage vs Count Binface: hard-right leader's UK poll gambit
-
Vast crowds mourn Khamenei in Iraq's holy cities
-
Hong Kong's Robert Wun: the bold Millennial conquering Haute Couture
-
Uber Eats, Deliveroo say will give France drivers break when too hot
-
IMF cuts 2026 world growth forecast, flags risks from new Mideast fighting
-
Trump tempers fury to end NATO summit on high note
-
Kostyuk sets up Wimbledon semi-final against Noskova
-
Oil shoots back up, stocks slide as Trump says Iran ceasefire over
-
Noskova reaches first Wimbledon semi-final
-
Kostyuk powers into second straight Slam semi-final at Wimbledon
-
Air Canada taps new CEO to replace chief who couldn't speak French
-
Israeli jails a 'graveyard,' says freed Palestinian journalist
-
Istanbul mayor ejected from court in corruption case
-
Family of last woman executed in UK wins posthumous pardon
-
Landslide kills eight at refugee school in Bangladesh
-
'Serial killer' German doctor given life sentence for 15 murders
-
Cleary leads NSW past Queensland to regain State of Origin crown
-
What is going on with Farage's UK election gambit?
-
MEXC Adds Nine Ondo Tokenized Stock and ETF Trading Pairs Tied to AI Infrastructure Demand
-
Dalic quits after 'incredible era' as Croatia coach
-
Oil prices surge, stocks slide as Trump says Iran ceasefire over
-
Bayeux tapestry to arrive in London in secret, high-stakes operation
-
Sunken wrecks, hot seas threaten fishermen on Italian isle
-
Messi World Cup magic masks familiar penalty frailty
-
Rescuers search for survivors of China storms as super typhoon nears
-
Trump lashes out at allies as key NATO summit begins
-
Egypt file complaint against referee after controversial World Cup exit
-
Swiss party into the night after reaching World Cup quarter-finals
-
Apple loses challenge against EU digital competition rules
-
Trump says Iran ceasefire 'over' after fighting flares
-
Trump says Iran ceasefire 'is over'
-
Thai beer dynasty mother drops 'ungrateful child' case against son
-
Rescuers search for missing in China storms after 100,000 flee
-
France v Morocco rematch as World Cup quarter-finals get under way
-
OpenAI to launch new model after US freeze
-
Modi visits Australia for minerals talks and rockstar welcome
First no-prescription birth control pill approved in US
US health authorities on Thursday approved the first over-the-counter birth control pill in the country, dramatically widening access to contraception for women in the United States where abortion rights are increasingly under assault.
The medication, Opill, will become available in pharmacies and supermarkets as well as online early next year, the manufacturer Perrigo said in a statement.
More than 100 countries already allow contraceptive pills to be sold over the counter. But in the United States approval comes after the Supreme Court last year scrapped federal abortion protections and the procedure is now banned in several states.
"Today's approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States," said Patrizia Cavazzoni, director of the Food and Drug Administration's Center for Drug Evaluation and Research in a statement.
"When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy."
The agency warned, however, that the pill should not be taken by women who have or have ever had breast cancer.
- 'Victory for equity' -
Almost half of the 6.1 million pregnancies in the United States each year are unintended, according to the FDA.
Allowing women to access the progestin-only daily contraceptive pill without needing to see a doctor first "may help reduce the number of unintended pregnancies and their potential negative impacts," the FDA statement said.
The pill, produced by the pharmaceutical company HRA Pharma, which was recently acquired by Perrigo, had already been authorized for prescription in the United States for a number of years.
"This moment is a victory for equity, human rights, public health, and evidence-based research—and especially in light of the ongoing attacks on reproductive health and rights, it is a reason to celebrate," said the Free the Pill coalition, a leading advocacy group.
Experts say the decision could be especially significant for teenage girls who may find it harder to get to the doctor, particularly if they want to do it on their own.
"An over-the-counter birth control pill has the potential to transform the way people access contraception, especially those who face the most barriers in our health care system, including LGBTQIA+ folks, people of color, and those working to make ends meet," said Lin-Fan Wang, a family physician serving the LGBTQ community and a Free the Pill member.
In May, an expert advisory committee convened by the FDA unanimously voted in favor of authorizing the sale of Perrigo without a prescription, judging that the benefits outweighed the risks.
The contraceptive pill, taken daily at the same time, prevents a pregnancy during sexual intercourse.
T.Bondarenko--BTB